Discrepant analyses of industry-sponsored clinical trials
Discrepancies between internal and published analyses of industry-sponsored clinical trials lead to further calls for transparency
Other
Jan 29, 2013 |
not rated yet |
0
Care transition initiative decreases rehospitalizations
(HealthDay)—Communities instituting quality improvement initiatives for care transitions see significant declines in the rate of 30-day rehospitalizations and hospitalizations, according to a study published ...
Health
Jan 23, 2013 |
not rated yet |
0
Drug companies forge partnerships with top schools
(AP)—Pharmaceutical companies that can no longer rely on lucrative patents to drive profits are increasingly teaming up with academia in search of the next big drug discovery.
Medications
Jan 10, 2013 |
3 / 5 (1) |
0
Direct costs for low back pain care in U.K. are substantial
(HealthDay)—The financial burden of caring for patients with chronic low back pain (CLBP) in the United Kingdom is twice that of caring for patients without CLBP, according to a study published in the Jan. ...
Health
Jan 03, 2013 |
not rated yet |
0
Drug trials in India 'causing havoc to human life'
India's Supreme Court said Thursday that unregulated clinical trials of new drugs were causing "havoc" in the country as it ordered the health ministry to monitor any new applications for tests.
Medications
Jan 03, 2013 |
5 / 5 (1) |
0
Big Pharma cashes in on HGH abuse
An Associated Press investigation shows that a federal crackdown on illicit foreign supplies of human growth hormone has failed to stop rampant misuse, and instead has driven record sales of the drug by some of the world's ...
Medications
Dec 21, 2012 |
not rated yet |
0
Public obsession with obesity may be more dangerous than obesity itself, UCLA author says
Much has been made about who or what is to blame for the "obesity epidemic" and what can or should be done to stem the tide of rising body mass among the U.S. population.
Overweight and Obesity
Dec 20, 2012 |
3.3 / 5 (3) |
0
|
Sleeping pills owe half their benefits to placebo effect, study finds
Half of the benefit of taking sleeping pills comes from the placebo effect, according to a major new study published in the British Medical Journal.
Medications
Dec 18, 2012 |
5 / 5 (3) |
0
|
Imeglimin beneficial as add-on to metformin in T2DM
(HealthDay)—For patients with type 2 diabetes inadequately controlled by metformin alone, addition of the new oral anti-diabetes agent imeglimin improves glycemic control with good tolerability and safety, ...
Diabetes
Dec 14, 2012 |
not rated yet |
0
Managing erectile dysfunction, comorbid diseases linked
(HealthDay)—Diagnosis and management of erectile dysfunction (ED) improves health outcomes for men with comorbid diseases, and vice versa, according to research published online Nov. 15 in The Journal of ...
Diseases, Conditions, Syndromes
Dec 03, 2012 |
not rated yet |
0
S.Africa seals record deal for low-cost ARVs: minister
South Africa, home to the world's largest population of people living with HIV, said Thursday it had secured a deal to buy a key anti-retroviral (ARV) drug at the lowest price ever.
HIV & AIDS
Nov 29, 2012 |
not rated yet |
0
Study links improved consumer welfare to increased prescription drug advertising efforts
More people are better off thanks to the impact of an influx of direct-to-consumer advertising spending than they would be without those marketing efforts, according to a study recently published by Jayani Jayawardhana, an ...
Medications
Nov 26, 2012 |
not rated yet |
0
Researchers to develop new diagnostic test for Chagas disease
(Medical Xpress)—Researchers at the University of Georgia will soon begin a study designed to identify new ways of determining treatment efficacy in Chagas disease, a potentially fatal tropical disease ...
Diseases, Conditions, Syndromes
Nov 22, 2012 |
5 / 5 (2) |
0
ACR: Strontium ranelate cuts progression of knee OA
(HealthDay)—The osteoporosis therapeutic strontium ranelate (SrRan) reduces radiographic and radiological progression of knee osteoarthritis, according to a study presented at the annual meeting of the ...
Arthritis & Rheumatism
Nov 12, 2012 |
not rated yet |
0
Canada high court voids Pfizer's Viagra patent
Canada's top court on Thursday stripped Pfizer of its patent for Viagra, saying the pharmaceutical giant failed in the patent to identify the active compound in the drug.
Medications
Nov 08, 2012 |
not rated yet |
0
